ArticleThe Lancet. Rheumatology2025

Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study.

Monique Hinchcliff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.